MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

被引:326
|
作者
Liu, Bo [1 ]
Peng, Xiao-Chun [2 ]
Zheng, Xiao-Li [3 ]
Wang, Jun [4 ]
Qin, Yong-Wen [1 ]
机构
[1] ChangHai Hosp, Cardiovasc Dept, Shanghai 200433, Peoples R China
[2] Shanghai Sixth Peoples Hosp, Dept Orthopaed, Shanghai, Peoples R China
[3] Second Mil Med Univ, Sch Pharm, Dept Pharmaceut, Shanghai, Peoples R China
[4] Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China
关键词
Lung cancer; miR-126; Vascular endothelial growth factor; Gene therapy; PROGNOSTIC VALUE; MICRORNAS; EXPRESSION; BEVACIZUMAB; CARBOPLATIN; PACLITAXEL; RECEPTORS; FLT-1;
D O I
10.1016/j.lungcan.2009.01.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vascular endothelial growth factor (VEGF) is a positive regulator of angiogenesis, and its expression is up-regulated in manycarcinomas. In the present study, we found that a microRNA miR-126 has a binding site in 3'-untranslated region of the VEGF-A mRNA. In eight lung cancer cell lines, expression of miR-126 was down-regulated. Reporter gene assay showed that the co-transfection of mir-126 expression vector with pLuc-VEGF/mir126BS could reduce the activity of luciferase. Transfection experiments showed that miR-126 could decrease the expression of VEGF-A. Three human lung carcinoma cell lines A549, Y-90 and SPC-A1 were investigated as cancer models in vitro, and A549 infected by lentivirus-miR-126 (LV-miR-126) was studied in tumor xenograft model. Infection of LV-miR-126 can down-regulate the expression of VEGF-A in A549, Y-90 and SPC-A1 cell lines and can inhibit the growth of these cells. In addition, flow cytometry analysis revealed that LV-miR-126 infection can induce cell cycle G1 arrest in A549, Y-90 and SPC-A1 cells. Furthermore, in nude mice, the average weight of A549 tumor nodules in experimental group was reduced from 0.8035 +/- 0.1521 to 0.6235 +/- 0.0757 g, with the inhibitive rate being 22.4%. All these results revealed that miR-126 may have a tumor suppressor function in lung cancer cells and could be a promising treatment in anticancer therapy. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [1] Inhibition of voltage-gated potassium channels affect expressions of miR-126 and miR-126*in breast cancer cell lines
    Cosan, Turgut D.
    Soyocak, A.
    Oner, C.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (02): : 111 - 116
  • [2] GLUCOCORTICOIDS DOWN-REGULATE DENDRITIC CELL-FUNCTION IN-VITRO AND IN-VIVO
    MOSER, M
    DESMEDT, T
    SORNASSE, T
    TIELEMANS, F
    CHENTOUFI, AA
    MURAILLE, E
    VANMECHELEN, C
    URBAIN, J
    LEO, O
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (10) : 2818 - 2824
  • [3] miR-599 and miR-185 down-regulate periostin expression in human lung cancer cells
    Wang, Yang
    Zheng, Jianming
    Yang, Lixin
    Jin, Hai
    Zuo, Changjing
    Sheng, Jing
    Chen, Wei
    Han, Yiping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2336 - 2344
  • [4] MIR-126*AND MIR-145 AS POTENTIAL BIOMARKERS FOR NON-SMALL CELL LUNG CANCER
    Fong, Alvin Hong-Wai
    Lai, Jessica Ka-Men
    Li, Jacky Yu-Chung
    Cho, William Chi-Shing
    RESPIROLOGY, 2018, 23 : 85 - 85
  • [5] Glucocorticoids down-regulate vascular endothelial growth factor (VEGF) production in renal cell carcinoma cells
    Iwai, A
    Fujii, Y
    Kawakami, S
    Takazawa, R
    Kageyama, Y
    Kihara, K
    JOURNAL OF UROLOGY, 2004, 171 (04): : 264 - 264
  • [6] Prognostic impact of miR-126 and miR-155 expression in non-small cell lung cancer
    Lonvik, K.
    Eklo, K.
    Berg, T.
    Donnem, Tom
    Bremnes, Roy
    Busund, Lill-Tove
    APMIS, 2010, 118 (03) : 248 - 249
  • [7] Independent and Tissue-Specific Prognostic Impact of miR-126 in Nonsmall Cell Lung Cancer
    Donnem, Tom
    Lonvik, Kenneth
    Eklo, Katrine
    Berg, Thomas
    Sorbye, Sveinung W.
    Al-Shibli, Khalid
    Al-Saad, Samer
    Andersen, Sigve
    Stenvold, Helge
    Bremnes, Roy M.
    Busund, Lill-Tove
    CANCER, 2011, 117 (14) : 3193 - 3200
  • [8] miR-126/VCAM-1 regulation by naringin suppresses cell growth of human non-small cell lung cancer
    Chen, Mingjiu
    Peng, Weilin
    Hu, Shifeng
    Deng, Jie
    ONCOLOGY LETTERS, 2018, 16 (04) : 4754 - 4760
  • [9] Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression
    Franco Grimolizzi
    Federica Monaco
    Francesca Leoni
    Massimo Bracci
    Sara Staffolani
    Cristiana Bersaglieri
    Simona Gaetani
    Matteo Valentino
    Monica Amati
    Corrado Rubini
    Franca Saccucci
    Jiri Neuzil
    Marco Tomasetti
    Lory Santarelli
    Scientific Reports, 7
  • [10] Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression
    Grimolizzi, Franco
    Monaco, Federica
    Leoni, Francesca
    Bracci, Massimo
    Staffolani, Sara
    Bersaglieri, Cristiana
    Gaetani, Simona
    Valentino, Matteo
    Amati, Monica
    Rubini, Corrado
    Saccucci, Franca
    Neuzil, Jiri
    Tomasetti, Marco
    Santarelli, Lory
    SCIENTIFIC REPORTS, 2017, 7